Observatoire des droits humains (anglais seulement)

AstraZeneca, Germany and over-65s: how to interpret confusing vaccine data

(Version anglaise seulement)

par Simon Kolstoe, Senior Lecturer in Evidence-Based Healthcare and University Ethics Advisor, University of Portsmouth

Germany has recently announced that it will not offer the AstraZeneca COVID-19 jab to over-65s due to insufficient data about its efficacy in that age group.

Meanwhile, initial data from Israel seemed to suggest that 14 days after the Pfizer/BioNTech first vaccine dose, patients only had a 33% reduced chance of infection – disappointingly…

Lire l'article complet